Provided by Tiger Fintech (Singapore) Pte. Ltd.

MoonLake Immunotherapeutics

53.09
-1.0900-2.01%
Post-market: 53.090.00000.00%18:00 EDT
Volume:379.92K
Turnover:20.40M
Market Cap:3.37B
PE:-23.04
High:54.63
Open:54.63
Low:52.86
Close:54.18
Loading ...
May 07, 2024

[Rev.]Annual Report

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
Mar 11, 2024

Major Issues Report

Form 8-K - Current report
Mar 05, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Feb 29, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 29, 2024

Major Issues Report

Form 8-K - Current report
Feb 26, 2024

Major Issues Report

Form 8-K - Current report
Feb 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 15, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 15, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 15, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Dec 21, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 20, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 14, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 14, 2023

Major Issues Report

Form 8-K - Current report
Nov 06, 2023

Major Issues Report

Form 8-K - Current report
Oct 16, 2023

Major Issues Report

Form 8-K - Current report
Sep 11, 2023

Major Issues Report

Form 8-K - Current report
Sep 08, 2023

Correspondence

Form CORRESP - Correspondence
Sep 01, 2023

Major Issues Report

Form 8-K - Current report